3001 - 3050 of 9156 Results
Title
Year
-
OPENTitle: Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 4329End Page: 4329Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-04254-yBest OA location URL: https://doi.org/10.1038/s41598-017-04254-yCitation Count: 28
-
OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: http://doi.org/10.1016/j.pnpbp.2016.05.004Citation Count: 27
-
OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://doi.org/10.5041/rmmj.10011Citation Count: 8
-
OPENTitle: Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 40263End Page: 40263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep40263Best OA location URL: https://www.nature.com/articles/srep40263.pdfCitation Count: 57
-
OPENTitle: n-3 PUFA supplementation benefits microglial responses to myelin pathologyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 7458End Page: 7458Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/srep07458Best OA location URL: https://www.nature.com/articles/srep07458.pdfCitation Count: 141
-
RESTRICTEDTitle: Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional rolesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 119-120Issue #:Start Page: 60End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2014.06.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4121732Citation Count: 0
-
OPENTitle: Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseasesJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 160089End Page: 160089Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2016.89Best OA location URL: https://www.nature.com/articles/sdata201689.pdfCitation Count: 533
- Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing2013OPENTitle: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencingJournal Name: RNAPublisher: Cold Spring Harbor LaboratoryVol: 19Issue #: 5Start Page: 712End Page: 722Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1261/rna.036863.112Best OA location URL: http://rnajournal.cshlp.org/content/19/5/712.full.pdfCitation Count: 189
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease2018OPENTitle: Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s DiseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 180036End Page: 180036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/sdata.2018.36Best OA location URL: https://www.nature.com/articles/sdata201836.pdfCitation Count: 268
-
OPENTitle: Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 324Issue #: 8Start Page: 772End Page: 772Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2020.12134Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2768841/jama_palmqvist_2020_oi_200077_1597950344.77871.pdfCitation Count: 1531
-
OPENTitle: Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegansJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 34477End Page: 34477Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep34477Best OA location URL: https://www.nature.com/articles/srep34477.pdfCitation Count: 455
-
OPENTitle: Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass SpectrometryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 5797End Page: 5797Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/srep05797Best OA location URL: https://www.nature.com/articles/srep05797.pdfCitation Count: 176
-
OPENTitle: Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 42Issue #:Start Page: 103592End Page: 103592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2024.103592Best OA location URL: https://doi.org/10.1016/j.nicl.2024.103592Citation Count: 5
-
OPENTitle: A new approach to assess gambling-like behavior in laboratory rats: using intracranial self-stimulation as a positive reinforcerJournal Name: Frontiers in Behavioral NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page: 215End Page: 215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnbeh.2014.00215Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00215/pdfCitation Count: 10
-
OPENTitle: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian RatsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 4Issue #: 3Start Page: 349End Page: 360Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-140410Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4154985Citation Count: 138
-
OPENTitle: MicelackingRas- GRF1 showcontextualfearcondition- ing butnotspatialmemoryimpair- ments:convergentevidencefromtwo independentlygeneratedmousemutant linesJournal Name: Frontiers in Behavioral NeurosciencePublisher: Frontiers Media SAVol:Issue #:Start Page: 78End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnbeh.2011.00078Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnbeh.2011.00078/pdfCitation Count: 33
-
OPENTitle: Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 7Issue #: 3Start Page: 503End Page: 509Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-171088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5909847Citation Count: 25
-
OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5501392Citation Count: 97
-
OPENTitle: ER proteostasis disturbances in Parkinson's disease: novel insightsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page: 39End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2015.00039Best OA location URL: https://doi.org/10.3389/fnagi.2015.00039Citation Count: 32
-
OPENTitle: Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page: 249End Page: 249Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00249Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00249/pdfCitation Count: 87
-
OPENTitle: Commentary: XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and LongevityJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page: 182End Page: 182Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00182Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00182/pdfCitation Count: 5
-
OPENTitle: Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression AnalysisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 46End Page: 46Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2016.00046Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2016.00046/pdfCitation Count: 36
-
OPENTitle: Subject-specific computational modeling of DBS in the PPTg areaJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 93End Page: 93Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2015.00093Best OA location URL: https://doi.org/10.3389/fncom.2015.00093Citation Count: 13
-
OPENTitle: Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorderJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page: 627End Page: 627Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2014.00627Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2014.00627/pdfCitation Count: 62
-
OPENTitle: Host and Microbial Factors in Regulation of T Cells in the IntestineJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2013.00141Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2013.00141/pdfCitation Count: 18
- Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency2009RESTRICTEDTitle: Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiencyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 15Issue #:Start Page: S42End Page: S45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(09)70778-3Citation Count: 123
-
OPENTitle: Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization ConsortiumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 10Start Page: e70752End Page: e70752Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70752Best OA location URL: https://doi.org/10.1002/alz.70752Citation Count: 22
-
OPENTitle: Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 3Issue #: 3Start Page: 116End Page: 132Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1159/000502951Best OA location URL: https://www.karger.com/Article/Pdf/502951Citation Count: 46
-
OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 26
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 26
-
OPENTitle: Understanding the Lexicon of Fatigue in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1185End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202029Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202029?id=journal-of-parkinsons-disease%2Fjpd202029Citation Count: 15
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 18
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial2011RESTRICTEDTitle: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 309End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4Citation Count: 674
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 13
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pubmed.ncbi.nlm.nih.gov/41191776/Citation Count: 2
- Biomarkers for Parkinson’s Disease2011RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page: 79ps14End Page: 79ps14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 41
-
OPENTitle: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol:Issue #:Start Page: 1316End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.011940Best OA location URL: https://doi.org/10.1242/dmm.011940Citation Count: 40
-
OPENTitle: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 284End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12915Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12915Citation Count: 20
-
OPENTitle: Remote Digital Monitoring for Medical Product DevelopmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 14Issue #: 1Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12851Citation Count: 22
-
OPENTitle: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial FinderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 5Issue #: 1Start Page: 55End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140522Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140522?id=journal-of-parkinsons-disease%2Fjpd140522Citation Count: 14
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: http://orbilu.uni.lu/handle/10993/17148Citation Count: 82